BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24387309)

  • 21. Management of metastatic melanoma.
    Tawbi HA; Kirkwood JM
    Semin Oncol; 2007 Dec; 34(6):532-45. PubMed ID: 18083377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical immunotherapy with diphenylcyclopropenone in combination with DTIC and radiation for cutaneous metastases of melanoma.
    Trefzer U; Sterry W
    Dermatology; 2005; 211(4):370-1. PubMed ID: 16286751
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
    Papadopoulos NE; Bedikian A; Ring S; Kim KB; Hwu WJ; Gerber DL; Homsi J; Hwu P
    Am J Clin Oncol; 2009 Oct; 32(5):509-14. PubMed ID: 19506454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature.
    Castro MP; VanAuken J; Spencer-Cisek P; Legha S; Sponzo RW
    Cancer; 1999 Mar; 85(5):1055-9. PubMed ID: 10091788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
    Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
    J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
    [No Abstract]   [Full Text] [Related]  

  • 26. Microphthalmos associated with Dartmouth combination chemotherapy in pregnancy: a case report.
    Li RH; Tam WH; Ng PC; Mok TS; Tam B; Lau TK
    J Reprod Med; 2007 Jun; 52(6):575-6. PubMed ID: 17694989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Has targeted therapy for melanoma made chemotherapy obsolete?
    Gibney GT; Sondak VK
    Lancet Oncol; 2013 Jul; 14(8):676-7. PubMed ID: 23816289
    [No Abstract]   [Full Text] [Related]  

  • 28. [Phototoxicity of dacarbazine (Deticene) not reinduced by temozolomide (Temodal)].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 1):500. PubMed ID: 16760848
    [No Abstract]   [Full Text] [Related]  

  • 29. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin].
    Maeda K; Miura S; Kawamura M; Jimbow K
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Ambinder EP; Holland JF
    Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
    [No Abstract]   [Full Text] [Related]  

  • 31. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
    Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R
    Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
    Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA
    Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 34. Re-evaluating the role of dacarbazine in metastatic melanoma: what have we learned in 30 years?
    Eggermont AM; Kirkwood JM
    Eur J Cancer; 2004 Aug; 40(12):1825-36. PubMed ID: 15288283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical trials of supplementary chemotherapy in cases of malignant melanoma of the skin with unfavorable prognosis after surgical treatment].
    Dobrek Z
    Wiad Lek; 1987 Feb; 40(4):237-41. PubMed ID: 3617746
    [No Abstract]   [Full Text] [Related]  

  • 36. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
    Hofmann MA; Sterry W; Trefzer U
    Jpn J Clin Oncol; 2007 Mar; 37(3):224-9. PubMed ID: 17472972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy.
    Legha SS
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S39-43. PubMed ID: 9122733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.
    McClay EF; Mastrangelo MJ; Bellet RE; Berd D
    Cancer Treat Rep; 1987 May; 71(5):465-9. PubMed ID: 3567970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L; Helmbold P; Emmert S; Marsch WC
    Hautarzt; 2002 Aug; 53(8):536-41. PubMed ID: 12221468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
    Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.